Tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate
C24H39N3O2 — CID 166926214
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate
Tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate (PubChem CID 166926214) has the molecular formula C24H39N3O2 and a molecular weight of 401.60 g/mol. Its IUPAC name is tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate |
|---|---|
| PubChem CID | 166926214 |
| Molecular Formula | C24H39N3O2 |
| Molecular Weight | 401.60 g/mol |
| Exact Mass | 401.30 |
| IUPAC Name | tert-butyl N-[1-[1-[4-[(1S)-1-aminoethyl]phenyl]-2-cyclopropylethyl]piperidin-4-yl]-N-methylcarbamate |
| SMILES | C[C@H](N)c1ccc(C(CC2CC2)N2CCC(N(C)C(=O)OC(C)(C)C)CC2)cc1 |
| InChI | InChI=1S/C24H39N3O2/c1-17(25)19-8-10-20(11-9-19)22(16-18-6-7-18)27-14-12-21(13-15-27)26(5)23(28)29-24(2,3)4/h8-11,17-18,21-22H,6-7,12-16,25H2,1-5H3/t17-,22?/m0/s1 |
| InChIKey | KYPNGESBDIHXTM-LBOXEOMUSA-N |
| XLogP | 4.88 |
| TPSA | 58.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 401.60 |
| LogP ≤ 5 | 4.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166926214 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.